APOTHEEK ROSSEEL
ActiveSummary
APOTHEEK ROSSEEL has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €114k and a net result of €16k. Equity is growing by ~37.1% per year across the filed fiscal years. Its solvency ranks better than 43% of 10359 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2025
67
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability74▼-4
Solvency56▲+4
Growth78=
Track record100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7k at 30 days acceptable
Liquidity short (current ratio 0.8 against 0.73 in 2024; short-term debt: 49.1% and cash: 17.4% of total assets), and 69.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
30.9%
Return on assets
4.4%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
27 d late
2024
1 d early
2023
on the day
2022
18 d late
2021
30 d late
2020
18 d late
2019
6 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€114k▲ 16.6%
2024 · €98k
2018: €-10k
2019: €6k
2020: €18k
2021: €34k
2022: €63k
2023: €72k
2024: €98k
2018 → 2025
Total assets
€370k▲ 0.8%
2024 · €367k
2018: €334k
2019: €334k
2020: €341k
2021: €334k
2022: €354k
2023: €353k
2024: €367k
2018 → 2025
Net result
€16k▼ 37.4%
2024 · €26k
2018: €5k
2019: €15k
2020: €12k
2021: €17k
2022: €28k
2023: €9k
2024: €26k
2018 → 2025
Working capital
€-36k▲ 26.5%
2024 · €-49k
2018: €-91k
2019: €-128k
2020: €-117k
2021: €-99k
2022: €-80k
2023: €-73k
2024: €-49k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€34k-€63k▲ 82.2%€72k▲ 15.1%€98k▲ 36.2%€114k▲ 16.6%
Operating result€30k-€46k▲ 51.1%€19k▼ 58.8%€42k▲ 122%€27k▼ 36.2%
Net result€17k-€28k▲ 70.2%€9k▼ 66.6%€26k▲ 176%€16k▼ 37.4%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 36% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €370k
Fixed assets
€225k ▼ 3.6%
Current assets
€145k ▲ 8.4%
Equity and liabilities €370k
Equity
€114k ▲ 16.6%
Debt
€256k ▼ 5.0%
Debt's share of the balance-sheet total falls from 73.3% to 69.1%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€35k▼
2024 · €50k
Cash flow
€25k▼
2024 · €34k
Current ratio
0.80▲
2024 · 0.73
Quick ratio
0.51▲
2024 · 0.47
Debt to equity
2.24▼
2024 · 2.75
ROE
14.2%▼
2024 · 26.6%
ROA
4.4%▼
2024 · 7.1%
Interest coverage
10.25▼
2024 · 13.26
Debt ≤ 1 year
€182k▼
2024 · €184k
Debt > 1 year
€74k▼
2024 · €86k
Income taxes
€7k▼
2024 · €12k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 50 lines
Balance sheet
Code20242025
Assets
Total assets20/58€367k€370k▲
Fixed assets21/28€233k€225k▼
Tangible fixed assets22/27€233k€225k▼
Land and buildings22€232k€224k▼
Furniture and vehicles24€2k€1k▼
Current assets29/58€134k€145k▲
Stocks and contracts in progress3€48k€52k▲
Stocks30/36€48k€52k▲
Amounts receivable within one year40/41€30k€29k▼
Trade receivables40€23k€23k▼
Other amounts receivable41€7k€7k▼
Cash at bank and in hand54/58€57k€65k▲
Equity and liabilities
Total equity and liabilities10/49€367k€370k▲
Equity10/15€98k€114k▲
Contributions10/11€15k€15k=
Capital10€15k-
Issued capital100€19k-
Uncalled capital101€4k-
Outside capital11-€15k
Other1109/19-€15k
Reserves13€82k€98k▲
Non-distributable reserves130/1€2k€2k=
Legal reserve130€2k-
Reserves not available under the articles1311-€2k
Distributable reserves133€80k€97k▲
Profit (loss) carried forward14€1k€1k=
Amounts payable17/49€269k€256k▼
Amounts payable after more than one year17€86k€74k▼
Financial debts170/4€86k€74k▼
Amounts payable within one year42/48€184k€182k▼
Current portion of amounts payable after more than one year42€11k€12k▲
Trade debts44€21k€27k▲
Suppliers440/4€21k€27k▲
Other amounts payable47/48€152k€143k▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€8k€8k▲
Other operating charges640/8€2k€2k▲
Gross operating margin9900€52k€37k▼
Operating profit (loss)9901€42k€27k▼
Financial income75/76B€0€1▲
Recurring financial income75€0€1▲
Financial charges65/66B€4k€3k▼
Recurring financial charges65€4k€3k▼
Profit (loss) for the period before taxes9903€38k€23k▼
Income taxes67/77€12k€7k▼
Profit (loss) for the period9904€26k€16k▼
Profit (loss) for the period to be appropriated9905€26k€16k▼
Appropriation of the result
Profit (loss) to be appropriated9906€27k€17k▼
Profit (loss) brought forward from the previous period14P€1k€1k=
Transfer to equity691/2€26k€16k▼
To other reserves6921€26k€16k▼
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 27 days late
2025
31-12
Financial
Equity above €100kEq €114k ▲16.6%
8 profitable years in a row build equity to €114k.
30-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
18-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 18 days late
2022
31-12
Financial
Highest result since 2018net €28k ▲70.2%
Operating result €46k, net result €28k, both a record.
30-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 30 days late
2021
18-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 18 days late
2020
06-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 6 days late
2019
03-09
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 34 days late
2018
31-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 31 days late
2017
29-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Huldenberg · 1 establishment unit since 2009
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Ganzemanstraat(NEE) 83040 HuldenbergGround area
492 m²
Building footprint
113 m²
Volume, LiDAR
521 m³
Parcel 24075B0404/00F000, Flanders · tallest building 6.0 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Apotheek Rosseel
since 20092.179.572.281
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24075B0404/00F000 | Flanders | 492 m² | 1 · 113 m² | 6.0 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteHuldenberg2.179.572.281
Similar companies · same sector, comparable size
APOTHEEK M. HEYLEN
BE 0422.188.639
Bocholt · Eq €114,437
APOTHEEK WILLEMS KLUIZEN
BE 0889.859.489
Evergem · Eq €114,106
PHARMA OGZ SRL
BE 0792.333.711
Brussel · Eq €114,039
Prieels Pharma
BE 0787.996.326
Oud-Heverlee · Eq €114,791
DECUPERE FARMA
BE 0795.305.968
Zonnebeke · Eq €113,857
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,479 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded24-06-2009
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 16 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.